The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.EBI
Development Center For Biotechnology
Synthesis of selenophene derivatives as novel CHK1 inhibitors.EBI
Development Center For Biotechnology
Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.EBI
Development Center For Biotechnology
Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.EBI
Development Center For Biotechnology
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.EBI
Development Center For Biotechnology
[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetesBDB
Eli Lilly
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitorsBDB
Astrazeneca
Apoptosis signal-regulating kinase inhibitorBDB
Gilead Sciences
Expanding the Scope of Human DNA Polymerase ¿ and ß Inhibitors.BDB
University of Konstanz
Identification of a small-molecule inhibitor of DNA topoisomerase II by proteomic profiling.BDB
Riken Advanced Science Institute